loader image

The Eurasian Patent Office (EAPO) as an International Searching Authority (ISA) under the PCT

On November 22, 2021, the Eurasian Patent Office (EAPO) and World Intellectual Property Organization (WIPO) signed the agreement according to which the EAPO can act as the International Searching Authority (ISA) and the International Preliminary Examining Authority (IPEA) under the PCT. The agreement will enter into force at a later date after completing necessary formality preparations by the patent office.

Calculation of compensation when producing patented drugs for export without patent owner’s consent

On October 18, 2021, the Government of the Russian Federation approved the methodology developed by the Federal Antimonopoly Service for calculating the amount of compensation payable to a Russian patent owner for producing generic medicines intended for export to other countries in accordance with the Article 1360.1 of the Civil Code without the patent owner’s consent. The corresponding government decree No 1767 entered into force on October 28, 2021.

According to Article 1360.1 of the Civil Code the Russian Government may allow to use a patented invention for the production of a medicinal product by any party for export purposes under certain specific circumstances without the consent of the patent owner with the requirement of immediate notification of the patent owner and payment of the proportionate compensation for such a use, as we informed earlier here.

The amount of compensation is 0.5% of the manufacturer’s actual revenue, which has exercised the right to use an invention, utility model or industrial design without the consent of the patent owner. The compensation is supposed to be annually paid during the period of validity of the corresponding government decision.

To date, no such authorization has been issued. We will follow up on the development of practice on this matter.

Should you have any questions in this regard or need additional information please do not hesitate to contact PATENTICA’s patent attorneys at  info@patentica.com.

An overview of the Eurasian design patent system

In the brand new issue of The Patent Lawyer Magazine: An overview of the Eurasian design patent system. Vasily Andreev and Victor Lisovenko, Attorneys at PATENTICA, summarise the filing, examination, and opposition stages of the Eurasian design patent system.

Read the full article here for free: https://lnkd.in/dpYYCYca

IP court upheld the right of the plaintiff to choose the method of protection for toy designs

PATENTICA ‘s lawyers successfully defended the interests of the toys manufacturer EPOCH COMPANY, LTD (Japan) in a dispute with a group of companies (importer Ababika LLC, toys wholesaler TNG LLC and administrator of online stores SP Zolnikov), on violation of copyright exclusive rights to “Sylvanian Families” (www.sylvanianfamilies.com) toy design.

The Intellectual Property Court, in cassation, ended a lengthy dispute and upheld the Ninth Arbitration Court of Appeal ruling to recover compensation for the defendants’ illegal distribution of Chinese counterfeit “Happy Friends” toys which the court found to be created using the images of characters designed by the Japanese company Epoch in view of the arguments presented by PATENTICA (www.patentica.com).

The proceedings took more than 4 years, going through several rounds in the first, appeal and cassation instances. In the first round, the courts of first and appeal instance sided with the defendant and refused to satisfy the claim due to the lack of registration of toys as industrial designs, the lack of proof of the sale of the disputed toys due to the formal discrepancy between the addresses of the defendants, and the impossibility of determining the proper defendant. However, the joint efforts of the designers of Epoch and Patentica lawyers Elena Dmitrenko and Alexander Tymofeev resulted in the victorious decision establishing the authorship rights of the original desiners of Sylvanian Families, so much loved by kids all over the world.

The Intellectual Property Court of the Russian Federation has completely revised the judicial acts of the first and the appellate instance and confirmed the erroneousness of the conclusions, recognizing the plaintiff’s right to choose the method of protecting the design of toys by copyright (and not just industrial designs), that the EPOCH COMPANY, LTD unambiguously has copyright for design of the toys, the right to recover compensation and the inadmissibility of excluding lawfully obtained evidence during the acquisition of counterfeit toys, such as till slip and invoices of online stores, when determining the fact of violation.

For more details, see https://kad.arbitr.ru/Card/da823344-1b49-4fea-93a9-aac3778c2fbb

Ksenia Emelianova

“Arte et humanitate, labore et scientia”.

Deep theoretical education and undying interest to the main tendencies in chemical science make Ksenia a bright IP specialist who can effectively handle various patent matters in chemistry, pharma, chemical engineering, material science and other technical fields .

Thorough analysis of application materials and careful attention to details help Ksenia to suggest the most effective strategy for overcoming examiners objections during prosecution and precisely reflect the client’s argumentation when preparing response to office actions.

In her spare time Ksenia enjoys trekking and mountain climbing.

Expertise

Prosecution of Russian and Eurasian patent applications
Patent drafting (RU, EA, PCT)
Patent opposition
Prior art and FTO searches
Translation and proofreading

Technical areas

Chemistry
Pharmaceuticals
Chemical engineering
Material science

Aleksandra Bulatova

“We can do it!”

Alexandra treats success of inventors as her own and exercises a thorough approach to solving each issue, striving to find the best path for every idea.

Alexandra really loves to travel and discover new worlds. She believes that new ideas of inventors are just as addictive as new countries, which is why she really enjoys her work.

Expertise

Prosecution of Inventions and Utility Models

Technical areas

IT
Mechanics
Electronics

Victor Lisovenko

“Think globally, act locally”.

Victor is an intellectual property attorney, registered to practice before the Russian and Eurasian patent offices, with main focus on patent law. His practice includes patent preparation and prosecution, appeals and oppositions, advisory and opinion work, litigation and licensing. Victor is a member of AIPPI, INTA, LES, Russian Chamber of Patent Attorneys and St. Petersburg Collegium of patent attorneys. He is a happy father of two kids, enjoys dynamic activities like football and beach volleyball in his spare time.

Client-oriented approach to work, forward-looking analytical skills coupled with substantial knowledge and valuable experience in the IP field make Victor a great patent attorney for various PATENTICA’s foreign and domestic clients in any patent-related matters.

Expertise

Patent drafting and prosecution at Rospatent and Eurasian Patent Office;
PCT Entry in Russian and Eurasia;
Patent searches (prior art searches, freedom-to-operate, etc)
Patent opposition and appeals at Rospatent, Eurasian PTO and Intellectual Property Court of Russia;
Patent due diligence;
Patent litigation;
Patent licensing;
Advisory and opinion work

Technical areas

Chemistry
Pharmaceuticals
Chemical engineering
Material science

Memberships

Russian Chamber of Patent Attorneys
AIPPI National Group
INTA
AIPLA
LES Russia

Agreement on electronic exchange of documents between EAPO and Rospatent

On 25 June 2021 a mutual agreement on electronic exchange of documents concerning Eurasian applications and patents was signed in Rospatent Moscow Headquarters by the President of EAPO and the Director General of Rospatent. This agreement shall allow both Offices to interact solely by electronic means of communication within Eurasian patent procedures, relevant to inventions and recently introduced industrial designs. Already existing and successfully running “EAPV-Online” system will be used and subsequently updated in order to directly integrate with RU PTO information systems.

https://rospatent.gov.ru/ru/news/soglashenie-eapv-rospatent-ob-elektronnom-obmene-dokumentami-25062021

We at PATENTICA. will be happy to answer any further questions you may have. Please feel free to contact us for more details at info@patentica.com.

Amendments to Patent fees Schedule introduced by the new Governmental Decree

On 17 June 2021 several amendments to the Official patent fees have been introduced, which came in force starting from 1 August 2021. The most important amendment concerns examination fees and establishes a uniform Official patent Substantive Examination fee of 12500 rubles for the first and 9200 rubles for every next independent claim instead of previous three substantive patent examination fees, which depended on the time when examination was requested. Official comments are expected to be announced soon.

The second amendment relates to the recent move to paperless Patent Office communication and on top of the regulation providing electronic forms of patents and trademark certificates as the default ones, the recent amendment now establishes an uniform fee of 2,000 RUR for any paper publication issued by request in addition to electronic ones. This regulation covers as well duplicates and paper publications of amendments that are handed out by Rospatent as confirmation of assignments or changes in owner’s (inventor’s) legal status, including a change of name or business name.

We at PATENTICA will be happy to answer any further questions you may have. Please feel free to contact us for more details at info@patentica.com.

Manufacture of patented drugs in Russia in special circumstances without the consent of the patent owner

On the 22nd of June, 2021, the Federal Law No. 212 as of June 11, 2021 entered into force, introducing an additional Article 1360.1 into part IV of the Civil Code.

According to Article 1360.1 of the Civil Code the Government of the Russian Federation may now allow to use a patented invention for the production of a medicinal product by any party for export purposes without the consent of the patent owner with the immediate notification of the patent owner and payment of the proportionate compensation for such a use.

The notification must disclose the information about a volume of production of a medicinal product defined by the needs of a foreign state where the medicinal product is to be exported, while the packaging of such a medicinal product should have a special designation “for export purposes” or the like.

On top of that according to earlier amendments to Article 1360 of the Civil Code of the Russian Federation introduced by the Federal Law No. 107 of April 30, 2021, the Government of the Russian Federation may allow to use an invention, utility model or industrial design without the consent of the patent holder, not only in the interests of the defense and security of the state, but also to protect the life and health of citizens in case of emergency.

The Government has once again expanded its powers and capabilities to use patented medicines in cases where the patent owner cannot fulfill the need of Russia’s and the Eurasian Economic Union’s (EAEU)* pharmaceutical markets with the required amount of medicines, especially with vital and essential drugs in difficult epidemiological situations and other undesirable circumstances.

Following this new provision the Russian company Pharmasintez has been recently given a permission to manufacture Remdesivir (used the treatment of COVID-19) without the consent of the originator company, Gilead Science. The decision is currently under court appeal submitted by the patent owner.

The adoption of the above-mentioned amendments clearly indicates the intention of the Russian Government to expand the application of the administrative procedure for authorizing the use of patented drugs over the whole territory of the Eurasian Economic Union and replace what is believed to be a controversial and widely criticized approach of issuing compulsory licenses in accordance with Article 1362 of the Civil Code of the Russian Federation.

While these provisions are clearly beneficial to generic manufacturers they also give an additional clear message to the originator companies about the importance of obtaining Eurasian patents covering not only Russia but the rest of the EAEU contracting states and other neighboring import-oriented countries.

Should you have any questions in this regard or need additional information please do not hesitate to contact PATENTICA’s patent attorneys at info@patentica.com.

*EAEU Contracting States: Russia, Armenia, Belarus, Kazakhstan, Kyrgyzstan